Edwards Lifesciences Corp (EW)
85.25
+0.19
(+0.22%)
USD |
NYSE |
May 03, 16:00
85.27
+0.02
(+0.02%)
Pre-Market: 20:00
Edwards Lifesciences Price to Book Value: 7.217 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 7.217 |
| May 02, 2024 | 7.201 |
| May 01, 2024 | 7.137 |
| April 30, 2024 | 7.168 |
| April 29, 2024 | 7.276 |
| April 26, 2024 | 7.317 |
| April 25, 2024 | 7.451 |
| April 24, 2024 | 7.499 |
| April 23, 2024 | 7.426 |
| April 22, 2024 | 7.360 |
| April 19, 2024 | 7.273 |
| April 18, 2024 | 7.316 |
| April 17, 2024 | 7.383 |
| April 16, 2024 | 7.621 |
| April 15, 2024 | 7.549 |
| April 12, 2024 | 7.641 |
| April 11, 2024 | 7.736 |
| April 10, 2024 | 7.745 |
| April 09, 2024 | 7.875 |
| April 08, 2024 | 7.815 |
| April 05, 2024 | 7.845 |
| April 04, 2024 | 7.718 |
| April 03, 2024 | 7.872 |
| April 02, 2024 | 7.982 |
| April 01, 2024 | 7.976 |
| Date | Value |
|---|---|
| March 31, 2024 | |
| March 28, 2024 | 8.650 |
| March 27, 2024 | 8.612 |
| March 26, 2024 | 8.456 |
| March 25, 2024 | 8.432 |
| March 22, 2024 | 8.489 |
| March 21, 2024 | 8.57 |
| March 20, 2024 | 8.422 |
| March 19, 2024 | 8.536 |
| March 18, 2024 | 8.404 |
| March 15, 2024 | 8.356 |
| March 14, 2024 | 8.450 |
| March 13, 2024 | 8.412 |
| March 12, 2024 | 8.229 |
| March 11, 2024 | 8.222 |
| March 08, 2024 | 8.340 |
| March 07, 2024 | 8.482 |
| March 06, 2024 | 7.986 |
| March 05, 2024 | 7.785 |
| March 04, 2024 | 7.868 |
| March 01, 2024 | 7.705 |
| February 29, 2024 | 7.674 |
| February 28, 2024 | 7.776 |
| February 27, 2024 | 7.822 |
| February 26, 2024 | 7.789 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.622
Minimum
Oct 27 2023
14.91
Maximum
Sep 08 2021
10.64
Average
11.27
Median
May 03 2022
Price to Book Value Benchmarks
| Stryker Corp | 6.526 |
| Align Technology Inc | 5.764 |
| Abbott Laboratories | 4.760 |
| Boston Scientific Corp | 5.375 |
| Steris PLC | 3.201 |
Price to Book Value Related Metrics
| PE Ratio | 36.75 |
| PS Ratio | 8.433 |
| Price to Free Cash Flow | 206.24 |
| Price | 85.25 |
| Earnings Yield | 2.72% |
| Market Cap | 51.37B |
| Operating PE Ratio | 29.86 |
| Normalized PE Ratio | 32.85 |